Company intelligence / Profile preview

Suzhou Rovathin Foreign Trade

Ownership: Private
Development stage: Commercial

Overview

Suzhou Rovathin Foreign Trade specializes in the design, synthesis, sales, and outsourcing of organic compounds—primarily small molecules and building blocks—for pharmaceutical, drug discovery, agrochemical, and biotechnology industries. The company is ISO 9001 certified and has delivered custom-synthesis products to major global pharmaceutical companies such as Roche, Novartis, Merck & Co., Wyeth, Amgen, Takeda, Johnson & Johnson, Boehringer Ingelheim among others. It does not develop its own therapeutic pipeline but acts as a key supplier for R&D programs worldwide.

Modalities: Small moleculeBuilding block/chemical intermediate
Industry: Chemicals & Materials

Partnerships

RocheNovartisMerck & Co.Wyeth/PfizerAmgenTakedaJohnson & JohnsonBoehringer Ingelheim

Beyond the preview

Go deeper on Suzhou Rovathin Foreign Trade.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Rovathin Foreign Trade.

Explore the full profile